// App-Quantinova.ai

11586 : A Novel MPO Inhibitor, PF-1355, Significantly Attenuates Disease Activity in Immune Complex Vasculitis and Glomerulonephritis Mouse Models

Researchers

Presenter

  • Wei Zheng

Principal Investigators

  • Roger Ruggeri

  • Christian Cortes

  • Kent Johnson

  • Athanasia Skoura

  • Roscoe Warner

  • Chunyan Su

  • Dexue Sun

  • Carlin Okerberg

  • Walter Bobrowski

  • Timothy Coskran

  • Amit Kalgutkar

Medical Centers

  • University of Michigan Medical School, Ann Arbor, MI

Locations

  • United States

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Urology

Disease

  • Glomerulonephritis

  • Renal insufficiency

  • Renal disease

  • Albuminuria

  • Venous thrombosis

Biomarkers

  • Myeloperoxidase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved